Pharmacological considerations in the modulation of multidrug resistance

被引：119

作者：

Fisher, GA

Lum, BL

Hausdorff, J

Sikic, BI

机构：

[1] Division of Medical Oncology, Stanford University Medical School, Stanford

来源：

EUROPEAN JOURNAL OF CANCER | 1996年 / 32A卷 / 06期

关键词：

D O I：

10.1016/0959-8049(96)00111-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1082 / 1088

页数：7

共 71 条

[61]

THALHAMMER T, 1994, ANTI-CANCER DRUG, V5, P16

[62] HIGH-DOSE ORAL TAMOXIFEN, A POTENTIAL MULTIDRUG-RESISTANCE-REVERSAL AGENT - PHASE-I TRIAL IN COMBINATION WITH VINBLASTINE [J].

TRUMP, DL ;

SMITH, DC ;

ELLIS, PG ;

ROGERS, MP ;

SCHOLD, SC ;

WINER, EP ;

PANELLA, TJ ;

JORDAN, VC ;

FINE, RL .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (23) :1811-1816

[63]

TSURUO T, 1983, CANCER RES, V43, P2267

[64]

Ukena D, 1995, CANCER CHEMOTH PHARM, V36, P160

[65]

VICKERS AEM, 1995, AM SOC PHARM EXP THE, V23, P321

[66] EFFECT OF COLCHICINE AND HEAT-SHOCK ON MULTIDRUG-RESISTANCE GENE AND P-GLYCOPROTEIN EXPRESSION IN RAT-LIVER [J].

VOLLRATH, V ;

WIELANDT, AM ;

ACUNA, C ;

DUARTE, I ;

ANDRADE, L ;

CHIANALE, J .

JOURNAL OF HEPATOLOGY, 1994, 21 (05) :754-763

[67] CONTROLLED TRIAL OF DEXVERAPAMIL, A MODULATOR OF MULTIDRUG-RESISTANCE, IN LYMPHOMAS REFRACTORY TO EPOCH CHEMOTHERAPY [J].

WILSON, WH ;

BATES, SE ;

FOJO, A ;

BRYANT, G ;

ZHAN, Z ;

REGIS, J ;

WITTES, RE ;

JAFFE, ES ;

STEINBERG, SM ;

HERDT, J ;

CHABNER, BA .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :1995-2004

[68] PHASE-I AND PHARMACOKINETIC STUDY OF THE MULTIDRUG-RESISTANCE MODULATOR DEXVERAPAMIL WITH EPOCH CHEMOTHERAPY [J].

WILSON, WH ;

JAMISDOW, C ;

BRYANT, G ;

BALIS, FM ;

KLECKER, RW ;

BATES, SE ;

CHABNER, BA ;

STEINBERG, SM ;

KOHLER, DR ;

WITTES, RE .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :1985-1994

[69] PHASE-I TRIAL OF ETOPOSIDE WITH CYCLOSPORINE AS A MODULATOR OF MULTIDRUG RESISTANCE [J].

YAHANDA, AM ;

ADLER, KM ;

FISHER, GA ;

BROPHY, NA ;

HALSEY, J ;

HARDY, RI ;

GOSLAND, MP ;

LUM, BL ;

SIKIC, BI .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (10) :1624-1634

[70]

YUEN A, 1995, P AM SOC CLIN ONCOL, V14, P392

← 1 2 3 4 5 6 7 8 →